Aortic thrombus in patients with severe COVID-19: review of three cases.
María de CarranzaDanilo-Eduardo SalazarJesús Troya GarcíaRoberto AlcázarCristina PeñaEsther AragónMarta DomínguezJuan TorresNuria Muñoz-RivasPublished in: Journal of thrombosis and thrombolysis (2021)
Coronavirus disease 2019 (COVID-19) could predispose to both venous and arterial thromboembolism, in an exaggerated immune response to the virus, especially in severe patients. Even though aortic clots are a rare entity, the pro-coagulant nature of COVID-19 is associated with thrombosis in atypical locations and should be considered in patients with severe abnormalities in coagulation parameters. We describe a series of three cases of aortic thrombi diagnosed by computerized tomography (CT) angiography in patients with confirmed SARS-CoV-2 infection.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- aortic valve
- early onset
- end stage renal disease
- left ventricular
- pulmonary artery
- aortic dissection
- newly diagnosed
- ejection fraction
- chronic kidney disease
- pulmonary embolism
- heart failure
- drug induced
- coronary artery
- atrial fibrillation
- anti inflammatory
- patient reported
- clinical decision support